Could a once-daily antibiotic dose beat the standard twice-daily regimen in ICU?
NCT ID NCT07258225
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a once-daily dose of the antibiotic tigecycline to the usual twice-daily schedule in 86 critically ill adults with multidrug-resistant infections. The goal is to see if the simpler regimen works just as well or better at clearing the infection and reducing side effects. Participants are in the ICU and must be 18 or older with certain infections like pneumonia or skin infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTI DRUG RESISTANT INFECTIONS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Air force specialized hospital
Cairo, Cairo Governorate, 11765, Egypt